Form 990 for tax year 2022

What the amendment changed

Compared with the latest return for 2022 , filed 4 March 2024. matched by us Only the Part I totals and the names listed in Part VII are compared. We relate returns by organization, tax year and form, and order them by each return's own timestamp; the filer's own "amended return" checkbox is a separate fact.

Both are the same on the two returns, so the amendment changed something else.

Totals

Total revenue

$225,088,441

Total expenses

$225,929,349

Contributions and grants received

$224,637,713

Grants paid

$29,668,766

Program service revenue

$0

Investment income

$401,915

Other revenue

$48,813

Total assets, end of year

$140,374,789

Total liabilities, end of year

$128,397,964

Net assets or fund balances, end of year

$11,976,825

Program services expenses (Part IX)

$208,902,900

Management and general expenses

$16,461,167

Fundraising expenses

$565,282

Program service expenses (Part III)

$208,902,900

Program services were 92.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2022

• OUR PROGRAMS AIM TO SAVE LIVES AND REDUCE THE BURDEN OF DISEASE, WHILE HELPING GOVERNMENTS CREATE SUSTAINABLE HEALTH SYSTEMS. WE OPERATE IN OVER 35 COUNTRIES WITH 20 PROGRAMS ACROSS FOUR HEALTH AREAS. THE VAST MAJORITY OF OUR STAFF ARE LOCATED IN THE COUNTRIES WHERE WE WORK, OVERSEEING IMPLEMENTATION AND MANAGING RELATIONSHIPS WITH PARTNER GOVERNMENTS. THE TEAMS ON THE GROUND ARE COMPLEMENTED BY A GLOBAL TEAM OF SCIENCE, BUSINESS, AND TECHNICAL EXPERTS SUPPORTING THE ENTIRE ORGANIZATION AND BY MANAGEMENT, FINANCE, AND HUMAN RESOURCE TEAMS. INFECTIOUS DISEASES: SEE SCHEDULE O FOR CONTINUATIONINFECTIOUS DISEASES: FOR YEARS, FOUR INFECTIOUS DISEASES DROVE MOST ILLNESS AND DEATH WORLDWIDE: HIV, HEPATITIS, TUBERCUOSIS (TB), AND MALARIA. IN 2020, A NEW ILLNESS, COVID-19 OVERTOOK THESE DISEASES AS THE LARGEST CAUSE OF GLOBAL MORTALITY BY AN INFECTIOUS DISEASE.EARLY ON, THE PANDEMIC BROUGHT MANY HEALTH SYSTEMS TO THEIR KNEES, AND IT CONTINUES TO EXPOSE AND EXACERBATE INEQUITIES THAT ALREADY EXISTED BETWEEN COUNTRIES, PEOPLE, AND ACCESS TO BASIC HEALTH SERVICES. IN 2022, CHAI CONTINUED TO SUPPORT COUNTRIES' LONGTERM RESPONSE TO COVID-19 AND STRENGTHEN HEALTH SYSTEM RESLIENCE TO PREPARE FOR FUTURE PANDEMICS.A CORE COMPONENT OF THIS WORK HAS BEEN STRENGTHENING ACCESS TO MEDICAL OXYGEN IN HEALTHCARE FACILITIES AND HOSPITALS IN LOW- AND MIDDLE-INCOME COUNTRIES THROUGH UPDATING INFRASTRUCTURE (I.E. BUILDING PSA PLANTS; SUPPORTING BEDSIDE DELIVERY OF LIQUID OXYGEN), KEEP OXYGEN EQUIPMENT UP AND RUNNING FOR ITS FULL LIFESPAN AND PROVIDING HEALTH WORKERS WITH THE RIGHT TOOLS, PROCESSES, AND PRACTICES TO SAVE LIVES.OTHER HIGHLIGHTS OF CHAI'S INFECTIOUS DISEASE PROGRAM WORK IN 2022 INCLUDE: A 10-COUNTRY PARTNERSHIP TO INTRODUCE COVID ORAL ANTIVIRALS AND NATIONAL TEST-AND-TREAT PROGRAMS IN AFRICA AND SOUTHEAST ASIA. THE COVID TREATMENT QUICK START CONSORTIUM SUPPORTS GOVERNMENTS TO INTRODUCE AND SCALE UP ACCESS TO NEW AND EFFECTIVE COVID-19 ORAL ANTIVIRAL THERAPIES IN HIGH-RISK POPULATIONS. KICK-STARTED WITH A DONATION OF ORIGINATOR TREATMENT COURSES, THE PROGRAM WILL SHIFT TO USING QUALITY-ASSURED, LOW-COST GENERICS WHEN THEY BECOME AVAILABLE TO FACILITATE WIDER ADOPTION. WORKING WITH VARIOUS TECH COMPANIES TO LOWER THE PRICE FOR HIV SELF-TESTS TO US$1. THE PRICE IS OVER 30 PERCENT BELOW THE CURRENT LOWEST-PRICED WHO-PREQUALIFIED TEST. THE WHO RECOMMENDS COUNTRIES IMPLEMENT SELF-TESTING AS A PART OF A DIFFERENTIATED AND COMPREHENSIVE APPROACH TO HIV TESTING SERVICES. REDUCING THE COST OF RIFAPENTINE-BASED TREATMENTS (1HP AND 3HP) TO PREVENT TUBERCULOSIS IN LOW- AND MIDDLE-INCOME COUNTRIES. 1HP AND 3HP BOTH CONTAIN RIFAPENTINE AND ISONIAZID AND ARE TWO OF SEVERAL REGIMENS RECOMMENDED FOR LATENT TB TREATMENT. THE REGIMENS SIGNIFICANTLY REDUCE DURATION OF TREATMENT AND PILL BURDEN, MAKING PATIENTS MORE LIKELY TO TAKE AND COMPLETE THE FULL TREATMENT CYCLE.

  Expenses $117,722,192 · Grants $19,271,298

• WOMEN & CHILDREN'S HEALTH: SEE SCHEDULE O FOR CONTINUATIONWOMEN & CHILDREN'S HEALTH: WWOMEN AND CHILDREN SUFFER THE GREATEST BURDEN FROM DISEASE GLOBALLY. CHAI HAS SIGNIFICANTLY INCREASED ACCESS TO RECOMMENDED TREATMENTS FOR DIARRHEA AND PNEUMONIA, THE LARGEST KILLERS OF CHILDREN UNDER FIVE; MADE CRITICAL VACCINES THAT PROTECT AGAINST CHILDHOOD ILLNESSES MORE AFFORDABLE; IS COMBATTING CHRONIC MALNUTRITION; AND IS DRAMATIALLY AND SUSTAINABLY REDUCING MATERNAL AND NEWBORN DEATHS AND ENSURING WOMEN HAVE ACCESS TO THE TOOLS THEY NEED TO SAFELY PLAN THER FAMILIES TO IMPROVE HEALTH OUTCOMES AND ECONOMIC WELLBEING.FOR EXAMPLE, WHEN CHAI BEGAN OUR DIARRHEA PROGRAM IN 2012, ONLY ONE-THIRD OF CHILDREN THAT NEEDED LIFESAVING ORAL REHYDRATION SOLUTIONS (ORS) RECEIVED IT. ZINC USAGE RATES WERE EVEN WORSE. THROUGH CHAI'S MARKET SHAPING WORK, WE HELPED REDUCE THE AVERAGE COST OF ZINC/ORS TREATMENT BY 42 PERCENT. WORKING WITH PARTNERS IN NIGERIA, INDIA, UGANDA, AND KENYA, WE ALSO INCREASED THE PERCENTAGE OF CHILDREN WITH DIARRHEA RECEIVING ZINC/ORS FROM LESS THAN ONE PERCENT TO 24 PERCENT.ANOTHER STRONG EXAMPLE IS CHAI'S WORK TO SAVE THE LIVES OF WOMEN AND NEWBORNS. CHAI HAS DEVELOPED AN INTEGRATED MATERNAL, NEWBORN, AND REPRODUCTIVE HEALTH STRATEGY THAT HAS CONTRIBUTED TO SUSTAINED AND SIGNFICANT REDUCTIONS IN DEATH IN COUNTRIES WHERE WE WORK. THIS APPROACH WAS FIRST PILOTED IN ETHIOPIA, BEFORE BEING TESTED AT SCALE IN NIGERIA, WHERE WE SAW A NEARLY 40 PERCENT REDUCTION IN MATERNAL MORTALITY AND A 43 PERCENT REDUCTION IN NEWBORN DEATHS IN A 12- MONTH PERIOD IN TARGET STATES OF NORTHERN NIGERIA. THE PROGRAM HAS BEEN ROLLED OUT MORE RECENTLY IN ZAMBIA AND UGANDA WITH SIMILAR RESULTS.

  Expenses $30,793,847 · Grants $6,001,503

• NON-COMMUNICABLE DISEASES: SEE SCHEDULE O FOR CONTINUATIONNON-COMMUNICABLE DISEASES: NON-COMMUNICABLE DISEASES (NCDS) SUCH AS HEART DISEASE, CANCER, CHRONIC RESPIRATORY DISEASE, AND DIABETES ARE THE LEADING CAUSE OF DEATH GLOBALLY, EXCEEDING ALL COMMUNICABLE DISEASE DEATHS COMBINED. DEATHS FROM NCDS IN LOW- AND MIDDLE-INCOME COUNTRIES ACCOUNT FOR AT LEAST 77 PERCENT OF ALL DEATHS GLOBALLY.CHAI WORKS WITH THE AMERICAN CANCER SOCIETY AND OTHER PARTNERS TO LOWER THE COST OF LIFESAVING CHEMOTHERAPIES, INCREASE ACCESS TO DIAGNOSIS AND TREATMENT, AND HELP GOVERNMENTS DEVELOP PLANS TO COMPREHENSIVELY MANAGE CANCERS. CHAI'S WORK HAS HELPED LOWER THE COST OF TREATMENT FOR 30 CANCERS, INCLUDING BREAST CANCER - THE MOST COMMONLY DIAGNOSED CANCER GLOBALLY - WHICH IS EXPECTED TO GENERATE SAVINGS OF 60 PERCENT ON PURCHASED MEDICATIONS. CHAI ALSO SUPPORTS GLOBAL EFFORTS TO ELIMINATE CERVICAL CANCER BY HELPING TO SUBSTANTIALLY INCREASE THE NUMBER OF WOMEN SCREENED FOR PRECANCEROUS LESIONS AND APPROPRIATELY TREATED. IN 2022, UNITAID-FUNDED PROGRAMS, INCLUDING OURS, REACHED AN IMPORTANT MILESTONE IN BURKINA FASO, COTE D'IVOIRE, MALAWI, NIGERIA, PHILIPPINES, RWANDA, AND SENEGAL, REACHING 90 PERCENT TREATMENT TARGETS FOR WOMEN IDENTIFIED WITH PRE-CANCEROUS LISIONS JUST TWO YEARS AFTER THE LAUNCH OF THE WHO CERVICAL CANCER ELIMINATION STRATEGY SEVEN YEARS AHEAD OF SCHEDULE.

  Expenses $34,726,595 · Grants $2,324,291

• ACHIEVING UNIVERSAL COVERAGE: CHAI'S FOUNDING MISSION AND ULTIMATE GOAL IS TO HELP COUNTRIES CREATE HIGH-QUALITY, SUSTAINABLE HEALTHCARE SYSTEMS THAT PROVIDE UNIVERSAL HEALTH COVERAGE FOR ALL PEOPLE. TO ACHIEVE THIS, WE WORK WITH GOVERNMENTS TO STRENGTHEN NATIONAL FINANCING SYSTEMS, INCLUDING ESTABLISHING NATIONAL HEALTH INSURANCE PLANS, THAT CAN BE SUSTAINED FOR YEARS TO COME. WE ALSO HELP DEVELOP SYSTEMS TO EDUCATE HEALTHCARE PROFESSIONALS AT ALL LEVELS AND TO BUILD SUFFICIENT PHYSICAL INFRASTRUCTURE TO DELIVER HEALTH SERVICES. THROUGH THIS WORK CHAI HAS SUPPORTED GOVERNMENTS TO SECURE OVER US$4 BILLION FOR HEALTH SYSTEMS STRENGTHENING, IMPROVED DATA BASED DECISION MAKING, INCREASED SYSTEM EFFICIENCIES, AND REDUCED COSTS. CHAI HAS HELPED GOVERNMENTS SUSTAINABLY TRAIN AND DEPLOY THOUSANDS OF HEALTH WORKERS IN THE COUNTRIES WHERE WE WORK TO IMPROVE LIFESAVING CARE AND REDUCE GAPS IN THE HEALTH SYSTEM.

  Expenses $22,789,440 · Grants $865,674

• CROSS-CUTTING EXPERTS: CHAI WORKS WITH GOVERNMENTS AND COMPANIES AROUND THE WORLD TO FUNDAMENTALLY CHANGE THE ECONOMICS OF GLOBAL HEALTH. USING A HOLISTIC, BUSINESS-MINDED APPROACH TO SECURE LOWER PRICES FOR KEY COMMODITIES SUCH AS MEDICATION AND DIAGNOSTICS, IMPROVE LABORATORIES, AND CONNECT DECISION-MAKERS WITH THE HIGH-QUALITY EVIDENCE THEY NEED TO INFORM HEALTH POLICY IN LOW- AND MIDDLE-INCOME COUNTRIES, CHAI HELPS PATIENTS ACCESS THE CARE AND TREATMENT THEY NEED. OUR SCIENCE AND BUSINESS EXPERTS WORK ACROSS THE ORGANIZATION TO SUPPORT OUR PROGRAM AND COUNTRY TEAMS.CHAI WORKS ON BOTH THE SUPPLY AND DEMAND SIDES OF THE MARKET TO LOWER COSTS AND INCREASE AVAILABILITY OF THE BEST HEALTH PRODUCTS FOR LOW-AND MIDDLE-INCOME COUNTRIES. WORKING WITH THE PUBLIC AND PRIVATE SECTORS, WE HELP SHAPE MARKETS AND REALIZE SAVINGS FOR DRUGS, DEVICES, AND DIAGNOSTICS IN ALL AREAS OF OUR WORK. CHAI HAS NEGOTIATED 135 GLOBAL AGREEMENTS TO LOWER PRICES OF CRITICAL MEDICATIONS AND OTHER HEALTH TOOLS BY 50-90 PERCENT. TWENTY-SEVEN MILLION PEOPLE LIVING WITH HIV HAVE BEEN REACHED BY ONE SUCH AGREEMENT LOWERING THE COST OF THE OPTIMAL HIV TREAMENT TLD, A SAVINGS OF OVER $500 MILLION. THROUGH THE GLOBAL HEALTH SCIENCES TEAM, CHAI AIMS TO REDUCE COSTS, IMPROVE QUALITY, AND INCREASE ACCESS TO TREATMENT BY HELPING TO DEVELOP LESS EXPENSIVE AND MORE EFFECTIVE VERSIONS OF CRITICAL MEDICATIONS FOR ADULTS AND CHILDREN; DEVELOPING TECHNIQUES AND TECHNOLOGIES THAT ADVANCE OUR UNDERSTANDING AND MANAGEMENT OF DISEASES; AND IMPROVE PATIENT CARE. THIS WORK HAS HELPED ACCELERATE BY OVER TWO YEARS DEVELOPMENT, MANUFACTURE, REGULATORY APPROVAL AND COMMERCIALIZATION OF KEY PEDIATRIC HIV PRODUCTS, AND SAVED BILLIONS IN COSTS TO GOVERNMENTS FOR CRITICAL TREATMENTS. SEVERAL NEW PROGRAMS HAVE ALSO BEEN ADDED TO CHAI'S PORTFOLIO IN RECENT YEARS, SIGNFICANTLY, CLIMATE CHANGE AND ASSISTIVE TECHNOLOGY.

  Expenses $2,541,311 · Grants $1,200,000

• INNOVATION.

  Expenses $329,515 · Grants $6,000

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• ELIZABETH GLAZER PEDIATRIC AIDS FOUNDATION DBA EGPAF

  $1,218,516

  HEALTH

• PATH

  $1,076,230

  HEALTH

• UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

  $802,913

  HEALTH

• JOHNS HOPKINS UNIVERSITY

  $505,552

  HEALTH

• THE UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER

  $503,000

  HEALTH

• CATHOLIC RELIEF SERVICES - UNITED STATES CONFERENCE OF CATHOLIC BISHOPS

  $369,698

  HEALTH

• PATHFINDER INTERNATIONAL

  $314,648

  HEALTH

• PARTNERS IN HEALTH

  $277,186

  HEALTH

• NOVARE CORPORATION INC

  $269,282

  HEALTH

• VAYU GLOBAL HEALTH FOUNDATION

  $143,000

  HEALTH

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

• CLINTON HEALTH ACCESS INITIATIVE CANADA

  HEALTH · CA · controlled entity

  Directly controlled by CLINTON HEALTH ACCESS INITIATIVE INC

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Provenance

Return type

form_990

Tax year

2022

Filed

15 November 2023

IRS schema version

2022v5.0

Source object

202313199349330441

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.